Navigation Links
Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Date:2/27/2013

SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6, 2013, at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time), at The Boston Marriott Copley Place in Boston, Massachusetts.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena PharmaceuticalsArena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors to address major therapeutic areas, including cardiovascular, central nervous system, inflammatory and metabolic diseases. BELVIQ® (lorcaserin HCl), Arena's internally discovered drug, was approved by the US Food and Drug Administration in June 2012, and is under review for regulatory approval in additional territories. Arena's US operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland. For more information, visit Arena's website at www.arenapharm.com.

Arena Pharmaceuticals® and Arena® are registered service marks of Arena Pharmaceuticals, Inc. BELVIQ® is
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
2. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
3. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
4. Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
5. Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference
6. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
9. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
11. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Eli Lilly and Company (NYSE: ... scams, purportedly using the name of the company and/or ... the public through postal mail solicitations and job-seekers through ... any foreign lottery organizations and do not conduct the ... of the scam. The activities described in these scams ...
(Date:6/19/2013)... , June 19, 2013   NextDocs announced ... service clinical research organization, at DIA 2013 , ... companies will present case studies that explore best practices ... to electronic trial master file (eTMF) systems. ... will present alongside Krystyna Kowalczyk , executive vice ...
(Date:6/19/2013)... , June 19, 2013   BioCision ... sample standardization and handling in many areas of ... of new patents by the U.S. Patent Office ... products developed to standardize sample handling to ensure ... results in common laboratory procedures. ...
Breaking Medicine Technology:Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2NextDocs and Novella to Present on eTMF at DIA 2013 2BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... 2012 Mylan Inc. (Nasdaq: MYL ) ... received final approval from the U.S. Food and Drug ... for Fluvastatin Capsules USP, 20 mg and 40 mg, ... Capsules. This product is indicated for the treatment of ...
... Maine, April 12, 2012 Expanding on the ... devices, Puritan Medical Products Co. LLC launches two ... use through its newly created division, Puritan Diagnostics ... Our universal transport media system has ...
Cached Medicine Technology:Mylan Launches First Generic Version of Lescol® Capsules 2Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems 2
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 North ... announced organizational changes to advance development of its ... said, “To support the advanced development of our ... changes to the Company’s management structure and engaged ... The Company announced that Michael Galiger will serve ...
(Date:6/19/2013)... Atlanta, Ga (PRWEB) June 19, 2013 ... billing and business management software solutions for the post-acute care ... position 79 - on the Healthcare Informatics 100 (HCI ... healthcare IT companies in the U.S. in terms of revenue ... grown at an average rate of 85% annually, and the ...
Breaking Medicine News(10 mins):Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3
... million commitment from James H. and Marilyn H. Simons ... as part of Memorial Sloan-Ketterings new Brain Tumor Center ... to achieve fundamental new insights into the molecular and ... plan to apply that knowledge to the creation of ...
... of Lifetime,s Nonpartisan Every Woman Counts Election Year, ... Issues That Matter Most -, NEW YORK, Feb. ... Heart Month, Lifetime Television launches its third annual Don,t,Skip ... the nation,s leading women,s health experts, the Network offers,a ...
... - The field of presidential contenders dwindled Wednesday when ... John Edwards (D-N.C.) dropped out of the race. ... frontrunners will continue to face a formidable challenge from ... season will intensify this weekend as the candidates visit ...
... Feb. 1 While winter,s harsh, windy weather,is often ... of lip,irritation is harder to pinpoint. In fact, several ... have been linked to dry lips. The,key is determining ... to eliminate the problem., Speaking today at the ...
... International Associates, Inc,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced,that effective at the opening of ... ALOG ) will replace Ventana Medical Systems,Inc. ... Index. Ventana,s is,being acquired by Roche group based ...
... ALLEGAN, Mich., Feb. 1 The Perrigo Company,(Nasdaq: ... Board of Directors has,authorized the repurchase of $150 ... 2010 under its ongoing share repurchase program. Any,remaining ... on,February 8, 2009. Under share repurchase programs since ...
Cached Medicine News:Health News:Simons Foundation grant boosts brain tumor research 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 3Health News:Election 2008: Sleep deprivation a tough opponent for presidential candidates 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 3Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 4
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
... is an Auto Refractor/Keratometer with ... refinement. Electronic elevation, automatic alignment, ... accuracy and all the other ... Marco Automatic Refractors/Keratometer famous, make ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: